Chimeric Antibodies:Addressing Current Challenges of Immunoassay Performance

来源 :2008中国深圳蛋白质和多肽科学大会 | 被引量 : 0次 | 上传用户:entine
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Amongst todays most relevant challenges in the immunodiagnostic field are the reduction of interassay variances and of assay interference as well as improved internal and external quality control.All of these challenges might be addressed by adaptation of isotype,origin and format of the employed antibodies according to the specific needs.Nowadays,improvement of assay performance can be achieved very elegantly by recombinant technologies which allow for the establishment of chimeric antibodies providing scaffolds with particular advantages.
其他文献
会议
会议
Using magnetic nanoparticles as a drug targeting carrier or imaging agent has attracted attention recently.In this report,a protein drug urokinase (UK) targeted by magnetic nanoparticles will be prese
会议
The recent SARS epidemic has boosted interest in the discovery of novel human and animal coronaviruses.By January 2008,more than 3000 coronavirus sequence records,including more than 250 complete geno
会议
A novel pH and temperature sensitive penta-block (PAE-PCL-PEG-PCL-PAE (poly (β-amino ester))) was synthesized followed by preparing poly (ethylene glycol)(PEG)-Poly (ε-caprolactone (CL)) (PCL-PEG-PCL)
会议
Matrix metalloproteinase-3 (MMP3) is well known as a secretory endopeptidase degrading extracellular matrices (ECM) and involved in many physiological and pathological processes.Recent reports indicat
会议
Polymeric amphiphiles consisting of hydrophilic and hydrophobic segments can form micelles or micelle-like self-assemblies with a hydrophobic core and a hydrophilic shell due to non-covalent associati
会议
An increasing number ofpeptides/proteins are being developed as therapeutic agents.However,peptides/proteins are generally much less stable than small molecule drugs.Their instability behavior greatly
会议
The biological risks associated to the administration of viral vectors for gene therapy have restricted the further development of viral vectors and seriously challenged their incorporation to clinica
会议
In recent years many proteins produced in large quantities by recombinant DNA techniques have become important new drugs.However,protein drugs possess several shortcomings,including susceptibility to
会议